INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $74,845 | -38.8% | 2,367 | -21.0% | 0.00% | -50.0% |
Q2 2023 | $122,218 | +22.1% | 2,997 | +11.6% | 0.00% | 0.0% |
Q1 2023 | $100,107 | +36.9% | 2,686 | +28.1% | 0.00% | +100.0% |
Q4 2022 | $73,129 | -45.4% | 2,096 | -12.2% | 0.00% | -66.7% |
Q3 2022 | $134,000 | +8.9% | 2,386 | +0.8% | 0.00% | +50.0% |
Q2 2022 | $123,000 | -21.2% | 2,368 | +10.2% | 0.00% | 0.0% |
Q1 2022 | $156,000 | -24.3% | 2,148 | +23.2% | 0.00% | -33.3% |
Q4 2021 | $206,000 | -13.4% | 1,743 | -1.6% | 0.00% | -25.0% |
Q3 2021 | $238,000 | -19.9% | 1,772 | -3.4% | 0.00% | -20.0% |
Q2 2021 | $297,000 | -99.9% | 1,834 | -35.8% | 0.01% | +150.0% |
Q1 2021 | $229,208,000 | +1432450.0% | 2,856 | +861.6% | 0.00% | – |
Q4 2020 | $16,000 | +300.0% | 297 | -25.8% | 0.00% | – |
Q1 2020 | $4,000 | -69.2% | 400 | -55.6% | 0.00% | – |
Q4 2019 | $13,000 | +8.3% | 900 | 0.0% | 0.00% | – |
Q3 2019 | $12,000 | +100.0% | 900 | +125.0% | 0.00% | – |
Q2 2019 | $6,000 | -45.5% | 400 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $11,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |